Home/Filings/4/0001415889-17-000023
4//SEC Filing

MABVAX THERAPEUTICS HOLDINGS, INC. 4

Accession 0001415889-17-000023

CIK 0001109196operating

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 9:00 PM ET

Size

5.4 KB

Accession

0001415889-17-000023

Insider Transaction Report

Form 4
Period: 2017-01-01
Resnick Paul F
Vice President, CBO
Transactions
  • Award

    Option to Purchase Common Stock

    2017-01-01$3.38/sh+15,200$51,37615,200 total
    Exercise: $3.38Exp: 2027-01-01Common Stock (15,200 underlying)
Footnotes (1)
  • [F1]Such Options shall vest in equal annual installments over a three year period.

Issuer

MABVAX THERAPEUTICS HOLDINGS, INC.

CIK 0001109196

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001109196

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 9:00 PM ET
Size
5.4 KB